We confirmed that the expression and activity of the inhibitory phosphatase SHIP1 is required to limit PI3K/AKT signaling in CLL cells to prevent excessive ROS production and thereby avoid an immunogenic form of cell death. This evidence concerns the gene AKT1 and B-cell chronic lymphocytic leukemia.